Increased full year 2024 revenue guidance to $200.M to $203.M from $197M to $200M representing growth of 34% to 36% compared to prior year. consensus is $198.12M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KIDS:
- KIDS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
- OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
- OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- OrthoPediatrics files $250M mixed securities shelf